The Economic Burden of Chronic Urticaria in Portugal: A Patient-Reported Cost-of-Illness Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patient-Reported Costs of Chronic Urticaria in Portugal: A Study of Its Economic Impact

  • By

  • Pedro S. Coelho

  • Jorge M. Mendes

  • João Maia Silva

  • October 14, 2026

Share

  • 1

    This cross-sectional, patient-reported study estimated annual chronic urticaria costs among adults in Portugal and examined direct-cost payers and productivity loss.

  • 2

    After weighting by population severity distribution, the estimated annual societal cost was €4687 per patient.

  • 3

    Presenteeism accounted for 62% of societal costs, while patients paid 64% of direct costs.

  • 4

    Among employed patients, each 1-point increase in DLQI was associated with €270 in annual productivity loss, independent of disease severity.

  • 5

    National cost estimates were indicative because chronic urticaria prevalence is uncertain and the sample's representativeness is limited.

Original Source(s)

The Economic Burden of Chronic Urticaria in Portugal: A Patient-Reported Cost-of-Illness Study

  • by Pedro S. Coelho, Jorge M. Mendes, João Maia Silva

  • October 14, 2026

Related Content

Reading Skin Cancer’s Molecular Fingerprint

Machine-learning models analyzed Raman spectra to distinguish cancerous tissue from normal skin

  • October 6, 2026

  • 2 min
Alopecia therapy gains FDA breakthrough status

The designation covers an investigational botanical treatment for moderate-to-severe alopecia areata in patients aged 2 years and older.

Diagnostic Value of Skin Biopsy in Fatal Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis: A Case Report